Company: YZY Biopharma Co Ltd
Job title: Chief Executive Officer
Dr. Zhou has over 20 years of experience in clinical oncology and therapeutic biologic R&D. He has extensive and in-depth experience in cancer biology and immunology. Dr. Zhou started his career as a surgeon in oncology and then postdoctoral scientist in immunology at Stanford University and Schering-Plough Biopharma (currently Merck Laboratories). Dr. Zhou obtained his PhD in molecular immunology from McMaster University (Canada) and MS degree in surgery (pediatric oncology) from Wuhan Tongji Medical University (China). Dr. Zhou has published more than 40 papers in immunology and 50 patents in antibody engineering and circulating tumor cells.
Preclinical Development of T Cell Redirecting Bispecific Antibodies 9:30 am
• Get an overview of the key challenges faced when carrying out preclinical development of bispecific antibodies • Learn how the PDX/Syngeneic models available can be used effectively to overcome these challenges • How to evaluate T cell induced cytokine storms in preclinical modelsRead more
day: Day Two